Feldan Therapeutics
PrivateLast Round
Grant
Mar 12, 2026
Total Funding Raised
$52.77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Feldan Therapeutics is a biopharmaceutical company specializing in the development of innovative treatments through advanced intracellular delivery technologies that enhance the safe and efficient transport of therapeutic compounds into cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Feldan Therapeutics Comparables
Compare Feldan Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Permeasis Therapeutics | 85% | |
| iDEL Therapeutics | 79% | |
| NanoSyrinx | 78% |
Feldan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 12, 2026 | ||||
| Grant | Sep 23, 2025 | ||||
| Series B | Apr 16, 2025 | ||||
| Strategic | Feb 18, 2025 | ||||
| Series B Extension | Sep 4, 2024 | ||||
Grant | Aug 28, 2023 |
Key People
Founding team and executive leadership
Feldan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Investissement Québec | Series B Extension, Series B |
| Investissement Québec | Series B, Strategic, Series B Extension |
| Fonds de solidarité FTQ | Strategic, Series B Extension |
| Consortium Québécois sur la découverte du médicament | Grant |
| Future Standard | Series B |
| Zynext Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 40% MoM.
- Jul 25, 2026
Monthly visitors grew 45% MoM.
Feldan Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Feldan Therapeutics's valuation, stock price, and market status.
Is Feldan a public or private company?
Feldan is a private company.
What is the current stock price of Feldan?
Feldan is a private company with no public stock price. No recent secondary market data is available.
How much is Feldan worth (valuation)?
Valuation information for Feldan is not publicly available.
Can I buy Feldan stock?
Feldan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Feldan's last funding round?
Feldan's most recent funding round was Series B on April 16, 2025.
Who are the main investors in Feldan?
Key investors in Feldan include Investissement Québec, Fonds de solidarité FTQ, Genesys Capital.
Will Feldan IPO soon?
No public IPO plans have been announced for Feldan.
How can I track Feldan secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Feldan's secondary market activity and sign up for updates.